Heart Failure Risk Cut Post-Attack with PR-364 Drug

PR-364

Researchers at Cedars-Sinai Medical Center have uncovered a groundbreaking discovery that could reshape post-heart attack care. A newly developed drug,…

Trending

Heart Failure Risk Cut Post-Attack with PR-364 Drug

PR-364

Researchers at Cedars-Sinai Medical Center have uncovered a groundbreaking discovery that could reshape post-heart attack care. A newly developed drug,…

COVID-19

Long Covid

Long COVID: Extended Paxlovid Treatment Offers Hope

A new case series by UC San Francisco (UCSF) suggests that an extended course of Paxlovid may provide relief for…

RSV Vaccine Response in Immunocompromised Adults

According to Johns Hopkins Medicine researchers, people 60 years or older with weakened immunity, primarily organ transplant recipients who take…

Gut Microbiome Predicts Long COVID Risk

In a recent pre-print study published on bioRxiv*, a team of researchers investigated the predictive role of gut microbiome composition…

Health and Wellness

PR-364

Heart Failure Risk Cut Post-Attack with PR-364 Drug

Researchers at Cedars-Sinai Medical Center have uncovered a groundbreaking discovery that could reshape post-heart attack care. A newly developed drug,…

PTSD, Anxiety Linked to Lower Ovarian Reserve in Firefighters

A recent study by the University of Arizona’s Mel and Enid Zuckerman College of Public Health, in collaboration with fire…

Art, Nature, and Meditation: Unique Brain Activation Patterns

Recent studies have shown that practices like meditation and exposure to art or nature can positively affect brain health and…